A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). I was asked to discuss the topic on ...
A bipartisan group of senators are filing a bill that would force health insurers or PBMs to divest their pharmacy businesses ...
With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback